RNA EDITING Flashcards
What is RNA editing
enables scientists to change the molecules that carry the instructions needed to produce proteins without changing the original DNA code.
MAY INCLUDE - insertion, deletion and substitution of nucleotides. (any thing other then splicing that changes RNA transcript)
RNA editing types (3)
- Adenosine deaminase actine on RNA (ADAR)
- Cas13
CRISPR Cas-inspired RNA targeting system (CIRTS)
What is ADAR (4)
RNA-binding protein.
- functions in RNA editing through post-transcriptional modification of mRNA transcripts by changing the nucleotide content of RNA.
- ADARs are expressed in human cells.
- ADAR family: ADAR1, ADAR2 (aka ADARB1) and ADAR3 – only 1 and 2 have catalytic activity.
ADAR CONVERSIONS
A to I in the RNA disrupts A:U pairing - making RNA unstable.
Inosine is structurally similar to guanine - which leads to I-to-C binding.
A to I deamination is the most abundant form of RNA editing in mammals.
Treatment ADAR for muscular dystrophies
AAV8 mediated ADAR RNA editing for MDx mouse model.
- nonsense mutation
- target Mdx mice via CRISPR-Cas9 excision of exon 23.
- ADAR1 double and used synthetic ADAR1 they could increase editing efficiency more then any other groups.
Cas13
- like Cas9, its a novel type of RNA-targeting enzyme
- The cas13 protein complexes with the guide RNA via recognition of a short hairpin in the crRNA – and target specific that is complementary to a target region.
Cas13 orthologs?
Cas13d – which has been leveraged for efficient and robust knockdown across many endogenous transcripts.
- Cas13d – used to modulate splicing of endogenous transcripts and that coding sequence for Cas13d is small enough to fit within packaging limits of AAV delivery.
- Cas13a / b/ c – too big. Which decreases deficiency due to dual delivery.
what has dCas13 been used for:
Has been used to target FTD with Parkinsonism linked to chromosome 17 – autosomal dominant major neurodegenerative disease caused by diverse point mutation in MAPT (encodes for tau).
- via AAV
what is REPAIR?
RNA editing for programmable A to I replacement (REPAIR) – works by fusing ADAR2 deaminase domain to Cas13b.
Disadvantages of REPAIR (3)
- Our body has naturally occurring Abs to CRISPR-Cas proteins.
- Also large size is challenging for packaging into a translation viral vector for direct protein delivery (130kDa in size)
- OVERCOME with CIRTS
what is CIRTS
CRISPR-Cas inspired RNA targeting system (CIRTS)
- Naturally occurring CRISPR-Cas programmable RNA binding system - made from human proteins
- avoids immune issues.
CIRT-6
Using CIRT-6 (optimal confirmation effector protein) – they could package entire thing into an AAV – making it much more appealing.
This is a good example of where you are removing bacterial components (using humanised protein) – no immune response, reducing RNA (by 50%), AND you can put it into an AAV.